These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16135636)

  • 1. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type.
    Neeman G; Blanaru M; Bloch B; Kremer I; Ermilov M; Javitt DC; Heresco-Levy U
    Am J Psychiatry; 2005 Sep; 162(9):1738-40. PubMed ID: 16135636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.
    Sumiyoshi T; Jin D; Jayathilake K; Lee M; Meltzer HY
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):451-5. PubMed ID: 15817136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
    Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
    J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
    Sumiyoshi T; Anil AE; Jin D; Jayathilake K; Lee M; Meltzer HY
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):1-8. PubMed ID: 14720317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
    Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
    Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
    Heresco-Levy U; Javitt DC; Ermilov M; Mordel C; Silipo G; Lichtenstein M
    Arch Gen Psychiatry; 1999 Jan; 56(1):29-36. PubMed ID: 9892253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
    Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
    Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive high-dose glycine in the treatment of schizophrenia.
    Javitt DC; Silipo G; Cienfuegos A; Shelley AM; Bark N; Park M; Lindenmayer JP; Suckow R; Zukin SR
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):385-91. PubMed ID: 11806864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?].
    Strzelecki D; Rabe-Jabłońska J
    Psychiatr Pol; 2010; 44(3):395-404. PubMed ID: 20672518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate, homocysteine, and negative symptoms in schizophrenia.
    Goff DC; Bottiglieri T; Arning E; Shih V; Freudenreich O; Evins AE; Henderson DC; Baer L; Coyle J
    Am J Psychiatry; 2004 Sep; 161(9):1705-8. PubMed ID: 15337665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-cycloserine added to clozapine for patients with schizophrenia.
    Goff DC; Tsai G; Manoach DS; Flood J; Darby DG; Coyle JT
    Am J Psychiatry; 1996 Dec; 153(12):1628-30. PubMed ID: 8942463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study].
    Strzelecki D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(6):825-37. PubMed ID: 22335126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-serine added to clozapine for the treatment of schizophrenia.
    Tsai GE; Yang P; Chung LC; Tsai IC; Tsai CW; Coyle JT
    Am J Psychiatry; 1999 Nov; 156(11):1822-5. PubMed ID: 10553752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
    Lane HY; Huang CL; Wu PL; Liu YC; Chang YC; Lin PY; Chen PW; Tsai G
    Biol Psychiatry; 2006 Sep; 60(6):645-9. PubMed ID: 16780811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophrenia.
    Ohnuma T; Sakai Y; Maeshima H; Higa M; Hanzawa R; Kitazawa M; Hotta Y; Katsuta N; Takebayashi Y; Shibata N; Arai H
    Int J Psychiatry Med; 2012; 44(1):17-27. PubMed ID: 23356091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
    Petronijević ND; Radonjić NV; Ivković MD; Marinković D; Piperski VD; Duricić BM; Paunović VR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1921-6. PubMed ID: 18824063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Libiger J
    Neuro Endocrinol Lett; 2008 Aug; 29(4):485-92. PubMed ID: 18766161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
    Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT
    Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.